Cargando…
Gout: An old disease in new perspective – A review
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood and described type of arthritis. Its epidemiology is studied. New insights into the pathophysiology of hyperuricemia and gouty arthritis; acute and chronic allow for an even better understanding of the diseas...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512152/ https://www.ncbi.nlm.nih.gov/pubmed/28748116 http://dx.doi.org/10.1016/j.jare.2017.04.008 |
_version_ | 1783250451279380480 |
---|---|
author | Ragab, Gaafar Elshahaly, Mohsen Bardin, Thomas |
author_facet | Ragab, Gaafar Elshahaly, Mohsen Bardin, Thomas |
author_sort | Ragab, Gaafar |
collection | PubMed |
description | Gout is a picturesque presentation of uric acid disturbance. It is the most well understood and described type of arthritis. Its epidemiology is studied. New insights into the pathophysiology of hyperuricemia and gouty arthritis; acute and chronic allow for an even better understanding of the disease. The role of genetic predisposition is becoming more evident. The clinical picture of gout is divided into asymptomatic hyperuricemia, acute gouty arthritis, intercritical period, and chronic tophaceous gout. Diagnosis is based on laboratory and radiological features. The gold standard of diagnosis is identification of characteristic MSU crystals in the synovial fluid using polarized light microscopy. Imaging modalities include conventional radiography, ultrasonography, conventional CT, Dual-Energy CT, Magnetic Resonance Imaging, nuclear scintigraphy, and positron emission tomography. There is remarkable progress in the application of ultrasonography and Dual-Energy CT which is bound to influence the diagnosis, staging, follow-up, and clinical research in the field. Management of gout includes management of flares, chronic gout and prevention of flares, as well as management of comorbidities. Newer drugs in the pharmacological armamentarium are proving successful and supplement older ones. Other important points in its management include patient education, diet and life style changes, as well as cessation of hyperuricemic drugs. |
format | Online Article Text |
id | pubmed-5512152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-55121522017-07-26 Gout: An old disease in new perspective – A review Ragab, Gaafar Elshahaly, Mohsen Bardin, Thomas J Adv Res Review Gout is a picturesque presentation of uric acid disturbance. It is the most well understood and described type of arthritis. Its epidemiology is studied. New insights into the pathophysiology of hyperuricemia and gouty arthritis; acute and chronic allow for an even better understanding of the disease. The role of genetic predisposition is becoming more evident. The clinical picture of gout is divided into asymptomatic hyperuricemia, acute gouty arthritis, intercritical period, and chronic tophaceous gout. Diagnosis is based on laboratory and radiological features. The gold standard of diagnosis is identification of characteristic MSU crystals in the synovial fluid using polarized light microscopy. Imaging modalities include conventional radiography, ultrasonography, conventional CT, Dual-Energy CT, Magnetic Resonance Imaging, nuclear scintigraphy, and positron emission tomography. There is remarkable progress in the application of ultrasonography and Dual-Energy CT which is bound to influence the diagnosis, staging, follow-up, and clinical research in the field. Management of gout includes management of flares, chronic gout and prevention of flares, as well as management of comorbidities. Newer drugs in the pharmacological armamentarium are proving successful and supplement older ones. Other important points in its management include patient education, diet and life style changes, as well as cessation of hyperuricemic drugs. Elsevier 2017-09 2017-05-10 /pmc/articles/PMC5512152/ /pubmed/28748116 http://dx.doi.org/10.1016/j.jare.2017.04.008 Text en © 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Ragab, Gaafar Elshahaly, Mohsen Bardin, Thomas Gout: An old disease in new perspective – A review |
title | Gout: An old disease in new perspective – A review |
title_full | Gout: An old disease in new perspective – A review |
title_fullStr | Gout: An old disease in new perspective – A review |
title_full_unstemmed | Gout: An old disease in new perspective – A review |
title_short | Gout: An old disease in new perspective – A review |
title_sort | gout: an old disease in new perspective – a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512152/ https://www.ncbi.nlm.nih.gov/pubmed/28748116 http://dx.doi.org/10.1016/j.jare.2017.04.008 |
work_keys_str_mv | AT ragabgaafar goutanolddiseaseinnewperspectiveareview AT elshahalymohsen goutanolddiseaseinnewperspectiveareview AT bardinthomas goutanolddiseaseinnewperspectiveareview |